CRM
CorMedix
Stock
Stock
ISIN: US21900C3088
Ticker: CRMD
US21900C3088
CRMD
Price
Price
CHART BY
Frequently asked questions
What is CorMedix's market capitalization?
The market capitalization of CorMedix is $858.46M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is CorMedix's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for CorMedix is 15.40. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for CorMedix?
CorMedix's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.747. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for CorMedix's stock?
Currently, 7 analysts cover CorMedix's stock, with a consensus target price of $18.71. Analyst ratings provide insights into the stock's expected performance.
What is CorMedix's revenue over the trailing twelve months?
Over the trailing twelve months, CorMedix reported a revenue of $121.48M.
What is the EBITDA for CorMedix?
CorMedix's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $49.93M. EBITDA measures the company's overall financial performance.
What is the free cash flow of CorMedix?
CorMedix has a free cash flow of $30.41M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does CorMedix have, and what sector and industry does it belong to?
CorMedix employs approximately 65 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of CorMedix's shares?
The free float of CorMedix is 66.88M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $858.46M
- EPS (TTM)
- $0.747
- Free Float
- 66.88M
- P/E ratio (TTM)
- 15.40
- Revenue (TTM)
- $121.48M
- EBITDA (TTM)
- $49.93M
- Free Cashflow (TTM)
- $30.41M
Pricing
- 1D span
- $11.62$12.59
- 52W span
- $4.675$17.40
Analyst Ratings
The price target is $18.71 and the stock is covered by 7 analysts.
Buy
6
Hold
1
Sell
0
Information
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.
- Employees
- 65
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- US21900C3088
- Primary Ticker
- CRMD
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet